Table 1 Age-adjusted cumulative prevalence a of amyloidosis, both overall and by gender (per 100,000 persons), along with 95% confidence intervals (CI)
Variable | 2006 | 2007 | 2008 | 2009 | 2010 | |||||
n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | |
All | 253 | 0.93 (0.81, 1.04) | 334 | 1.17 (1.04, 1.30) | 376 | 1.26 (1.13, 1.39) | 414 | 1.31 (1.18, 1.44) | 424 | 1.30 (1.18, 1.43) |
20–44 years old | 58 | 0.28 (0.20, 0.35) | 60 | 0.29 (0.21, 0.36) | 71 | 0.35 (0.27, 0.43) | 87 | 0.43 (0.34, 0.53) | 65 | 0.32 (0.24, 0.40) |
45–64 years old | 111 | 0.97 (0.79, 1.15) | 164 | 1.38 (1.17, 1.59) | 169 | 1.37 (1.16, 1.58) | 192 | 1.50 (1.29, 1.73) | 220 | 1.66 (1.44, 1.89) |
Over 65 years | 84 | 2.05 (1.61, 2.49) | 110 | 2.49 (2.02, 2.96) | 136 | 2.95 (2.45, 3.45) | 135 | 2.78 (2.31, 3.25) | 139 | 2.78 (2.32, 3.24) |
Men | 118 | 0.43 (0.35, 0.51) | 172 | 0.60 (0.51, 0.69) | 187 | 0.62 (0.53, 0.71) | 231 | 0.73 (0.63, 0.83) | 230 | 0.71 (0.61, 0.80) |
20–44 years old | 30 | 0.14 (0.09, 0.19) | 31 | 0.14 (0.09, 0.20) | 39 | 0.19 (0.13, 0.25) | 48 | 0.23 (0.16, 0.30) | 38 | 0.18 (0.12, 0.25) |
45–64 years old | 44 | 0.37 (0.26, 0.49) | 82 | 0.69 (0.54, 0.84) | 81 | 0.65 (0.51, 0.80) | 104 | 0.81 (0.66, 0.97) | 108 | 0.81 (0.66, 0.97) |
Over 65 years | 44 | 1.06 (0.74, 1.38) | 59 | 1.33 (0.99, 1.68) | 67 | 1.44 (1.09, 1.79) | 79 | 1.62 (1.26, 1.98) | 84 | 1.67 (1.31, 2.03) |
Women | 135 | 0.49 (0.40, 0.57) | 162 | 0.56 (0.47, 0.65) | 189 | 0.63 (0.54, 0.73) | 183 | 0.57 (0.49, 0.66) | 194 | 0.59 (0.51, 0.68) |
20–44 years old | 28 | 0.13 (0.08, 0.18) | 29 | 0.14 (0.09, 0.19) | 32 | 0.15 (0.09, 0.21) | 39 | 0.19 (0.13, 0.25) | 27 | 0.13 (0.08, 0.18) |
45–64 years old | 67 | 0.58 (0.44, 0.72) | 82 | 0.69 (0.54, 0.84) | 88 | 0.71 (0.56, 0.86) | 88 | 0.69 (0.54, 0.83) | 112 | 0.84 (0.68, 1.00) |
Over 65 years | 40 | 0.97 (0.66, 1.27) | 51 | 1.15 (0.83, 1.47) | 69 | 1.49 (1.13, 1.84) | 56 | 1.15 (0.85, 1.46) | 55 | 1.09 (0.80, 1.38) |
Variable | 2011 | 2012 | 2013 | 2014 | 2015 | |||||
n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | n | Prevalence (95% CI) | |
All | 454 | 1.35 (1.22, 1.47) | 577 | 1.64 (1.50, 1.77) | 638 | 1.71 (1.58, 1.85) | 725 | 1.86 (1.73, 2.00) | 771 | 1.91 (1.78, 2.05) |
20–44 years old | 63 | 0.32 (0.24, 0.40) | 76 | 0.38 (0.30, 0.47) | 90 | 0.46 (0.36, 0.56) | 104 | 0.54 (0.43, 0.64) | 103 | 0.54 (0.43, 0.64) |
45–64 years old | 218 | 1.59 (1.38, 1.80) | 269 | 1.92 (1.69, 2.15) | 320 | 2.21 (1.97, 2.45) | 343 | 2.30 (2.05, 2.54) | 361 | 2.35 (2.11, 2.59) |
Over 65 years | 173 | 3.33 (2.83, 3.83) | 232 | 4.23 (3.68, 4.77) | 228 | 3.95 (3.44, 4.47) | 278 | 4.62 (4.08, 5.17) | 307 | 4.93 (4.38, 5.48) |
Men | 235 | 0.69 (0.60, 0.78) | 305 | 0.86 (0.76, 0.95) | 355 | 0.95 (0.85, 1.05) | 372 | 0.95 (0.86, 1.05) | 420 | 1.04 (0.94, 1.14) |
20–44 years old | 34 | 0.17 (0.11, 0.23) | 48 | 0.24 (0.17, 0.31) | 52 | 0.26 (0.19, 0.33) | 57 | 0.29 (0.21, 0.37) | 57 | 0.29 (0.22, 0.37) |
45–64 years old | 106 | 0.77 (0.62, 0.92) | 138 | 0.98 (0.81, 1.14) | 164 | 1.13 (0.95, 1.30) | 169 | 1.13 (0.95, 1.30) | 182 | 1.18 (1.01, 1.35) |
Over 65 years | 95 | 1.82 (1.45, 2.19) | 119 | 2.16 (1.77, 2.55) | 139 | 2.42 (2.01, 2.82) | 146 | 2.42 (2.02, 2.81) | 181 | 2.90 (2.48, 3.33) |
Women | 219 | 0.64 (0.56, 0.73) | 272 | 0.77 (0.68, 0.86) | 283 | 0.75 (0.66, 0.84) | 353 | 0.90 (0.81, 1.00) | 351 | 0.87 (0.77, 0.96) |
20–44 years old | 29 | 0.14 (0.09, 0.19) | 28 | 0.13 (0.08, 0.19) | 38 | 0.19 (0.13, 0.25) | 47 | 0.24 (0.17, 0.31) | 46 | 0.23 (0.16, 0.30) |
45–64 years old | 112 | 0.81 (0.66, 0.97) | 131 | 0.93 (0.77, 1.09) | 156 | 1.07 (0.90, 1.24) | 174 | 1.16 (0.99, 1.33) | 179 | 1.16 (0.99, 1.33) |
Over 65 years | 78 | 1.49 (1.15, 1.82) | 113 | 2.05 (1.67, 2.43) | 89 | 1.53 (1.21, 1.85) | 132 | 2.19 (1.81, 2.56) | 126 | 2.02 (1.67, 2.37) |